New Clinical Trial Will Test How Baricitinib Improves Neurocognitive Function in Patients with Long Covid

People with Long Covid may participate in an important new clinical trial—the REVERSE-LC trial (Evaluating Baricitinib on Persistent Neurologic and Cardiopulmonary Symptoms of Long COVID)—which will test whether the drug […]